Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Thoracic Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04912687 2026-03-06

CIRCULAR

Phase NA Completed

581 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07432308 2026-03-06

Liquid biopsy

Phase NA Completed

22 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01279408 2026-03-04

Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)

Completed

46 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03083041 2026-03-03

A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

Phase 2 Completed

210 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02738398 2026-02-27

FDG PET/CT in Lung Cancer Staging

Phase NA Completed

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03564197 2026-02-27

18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC

Phase NA Completed

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03724331 2026-02-24

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

Phase NA Completed

235 enrolled 17 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms, Motor Activity

NCT05263947 2026-02-24

Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation

Phase 2 Completed

35 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03088540 2026-02-23

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

712 enrolled 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04738487 2026-02-20

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

Phase 3 Completed

1,264 enrolled 16 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07192926 2026-02-20

SARCO-CTI

Completed

131 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT03829332 2026-02-19

LEAP-007

Phase 3 Completed

623 enrolled 26 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Clinical Trials

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Study of DF1001 in Patients With Advanced Solid Tumors

A Study of DF6002 Alone and in Combination With Nivolumab

Study of DF6215 in Patients With Advanced Solid Tumors

PEARLS

TOP 1501

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

LBM-T790M

MetLung

CB(NPC)²

Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer

Priming Immunotherapy in Advanced Disease With Radiation

SPRINT

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled

UNCOVER

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

CIRCULAR

Liquid biopsy

Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)

A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

FDG PET/CT in Lung Cancer Staging

18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

SARCO-CTI

LEAP-007